19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Women's Health
Resources
Basic InformationLatest News
Affordable Care Act Brought Big Benefits to Women: StudyIs There a Safer Choice Than Opioids After a C-Section?Three Clues to Raised Risk of MiscarriageFDA Approves First Drug for Postpartum DepressionWhat Works Best for Women Struggling With a Leaky Bladder?Even Housework, Gardening Can Help an Older Woman's HeartAHA News: Black Woman in Their 50s Face Especially High Stroke RiskEarly-Onset Menstruation Linked to Later High Blood Pressure RiskClaire's Recalls 3 Cosmetic Products Due to Possible Asbestos ContaminationScientists Spot Clues to Predicting Breast Cancer's ReturnAre Some Birth Control Methods Doomed to Fail?AHA News: Belly Fat Ups Older Women's Heart Risks, Even Without ObesityHormone Therapy Linked to Slight Rise in Alzheimer's RiskFDA Issues Asbestos Warning About Some Claire's Cosmetic ProductsHigh Deductibles May Threaten Breast Cancer Patients' SurvivalHow Soon Should You Conceive After a Stillbirth?Lifestyle Changes Can Lower Your Breast Cancer RiskPrenatal Vitamins Might Lower Risk of Second Child With AutismLong Work Weeks May Be Depressing, Especially for WomenSingle Moms Often Put Kids' Health Care First, Study FindsCervical 'Microbiome' Could Help Predict Cancer RiskDon't Be Fooled: Thermography No Substitute for Mammograms, FDA SaysWhat's the Right Age to Test for Osteoporosis?Most Nations May Be Rid of Cervical Cancer By 2100HPV Infections Most Tied to Cancer Are in Decline, and Vaccines May Be WhyExperimental Drug Helps Women With Deadly Type of Breast CancerAHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?Acupuncture Could Help Ease Menopausal SymptomsAHA News: Could 'Cardio-Obstetrics' Curb Rise in Pregnancy-Related Deaths?Should You Get Tested for the 'Breast Cancer Genes'?Common Yeast Infection Treatment Tied to Miscarriage, Birth DefectsHeart Attacks Rising Among Younger WomenBreast Cancer and DDT: Timing of Exposure May MatterCould Diet Sodas Raise an Older Woman's Stroke Risk?Mammograms Helped Save Up to 600,000 U.S. Lives Since 1989: StudyAHA News: Pregnancy May Raise Risk of Deadliest Type of StrokeAHA News: Many Women Plagued by Anxiety After StrokeBenign Ovarian Cysts Should Be Left in Place, Study SuggestsToo Much TV Raises Women's Odds for Early-Onset Colon Cancer: StudyWomen's Brains May Be More 'Age-Resistant' Than Men'sHealth Screenings Every Woman NeedsAHA: Could a Heart Attack or Stroke Lead to Early Menopause?Breast Cancer May Bring Higher Odds for A-fib, TooHealth Tip: Help Prevent Cervical CancerUterus 'Scratching' Technique Won't Boost Fertility Treatment SuccessMoms, Are You Victims of 'Invisible Labor'?Mindfulness Might Ease Menopause SymptomsBody Size May Influence Longevity in Women, But Not MenHPV Vaccine Even Helps Women Who Didn't Get It: StudyAt Risk for Breast Cancer? Your Race Matters
Questions and AnswersVideosLinksBook ReviewsSelf-Help Groups
Related Topics

Wellness and Personal Development
Mental Disorders

Hormone Therapy Linked to Slight Rise in Alzheimer's Risk

HealthDay News
by By Serena Gordon
HealthDay Reporter
Updated: Mar 7th 2019

new article illustration

THURSDAY, March 7, 2019 (HealthDay News) -- Many women turn to hormone therapy to ease some of the more troubling symptoms of menopause, such as hot flashes and night sweats.

But new research suggests that relief may come at a cost -- an increased risk of Alzheimer's disease.

The study found that women taking hormone therapy had a 9 percent to 17 percent higher risk of developing Alzheimer's disease. In women who began taking hormone therapy before age 60, this increased risk was tied to long-term use of a decade or longer.

"The take-home message is that, in absolute terms, nine to 18 excess diagnoses of Alzheimer's disease per year will be detected in 10,000 women aged 70 to 80, especially in those women who had used hormone therapy for over 10 years," said study senior author Dr. Tomi Mikkola. He is an associate professor in the department of obstetrics and gynecology at Helsinki University Hospital in Finland.

The study was published online March 6 in the BMJ, along with an accompanying editorial.

One of the authors of that editorial, Dr. JoAnn Manson, chief of the division of preventive medicine at Brigham and Women's Hospital in Boston, said the findings from this study are "not a cause for alarm."

"Overall, the research has been reassuring for younger women in early menopause who are seeking treatment for night sweats and hot flashes. Based on the totality of evidence, there appears to be relative safety for hormone therapy when taken in early menopause," she said.

Manson also pointed out that due to the study's design, it can only show an association, not a cause-and-effect relationship.

It's been almost 20 years since concerns were first raised about the possible health effects of hormone therapy, including increased heart and cancer risks. Studies since then have often had mixed results, including studies looking at memory and thinking abilities in women taking hormone therapy.

Some research has suggested that women who take hormones to ease menopausal symptoms may be less at risk of developing Alzheimer's disease, while others show no harm or benefit. Now, the latest study suggests a possible increase in risk.

Both Mikkola and Manson said hormone therapy shouldn't be used specifically to try to prevent Alzheimer's disease.

But, if you're a woman experiencing menopausal symptoms that are affecting your quality of life, Manson said, "concern about Alzheimer's disease or cognitive [thinking] decline should not interfere with menopausal symptom management."

However, Mikkola noted that any woman taking hormone therapy for 10 years or more should be advised that they may have an increased risk of the memory-robbing disorder.

The study looked at nearly 85,000 postmenopausal women diagnosed with Alzheimer's in Finland from 1999 to 2013. The researchers compared these women to women who hadn't been diagnosed with Alzheimer's disease.

Nearly all of the women with Alzheimer's were diagnosed after 60. More than half were over 80 at the time of diagnosis, the findings showed.

The investigators reviewed health records to see if women were taking hormone replacement therapy. If they were, the researchers looked to see how long they had been taking it.

There are a number of different forms of hormone replacement therapy, including pills, patches, gels and creams. Ninety percent of hormone replacement therapy is given by pill in Finland, the study authors noted.

Three-quarters of the women had been taking hormone therapy for more than 10 years, according to the report.

The study didn't find a difference in Alzheimer's risk based on the formulation of hormone therapy. The risk was similar whether women took estrogen alone, or estrogen and progesterone together.

Mikkola explained that "the absolute risk increase for Alzheimer's disease is small," and said that the study "emphasizes the fact that hormone therapy should be used in recently menopausal women for symptom relief and if they benefit from the therapy."

Editorial author Manson said that the decision about whether or not to use hormone therapy has to be individualized. She said a woman and her doctor have to take into account a woman's risk factors, symptoms and preferences.

More information

Learn more about what causes Alzheimer's disease from the U.S. National Institute on Aging.